Smita Joshi

Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study

Rengaswamy Sankaranarayanan, Priya R. Prabhu, Michael Pawlita et al. · The Lancet Oncology · 2015 · 244 citations · Full text

Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination

Smita Joshi, Devasena Anantharaman, Richard Muwonge et al. · Vaccine · 2022 · 81 citations · Full text

Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial

Hitt Sharma, Sameer Parekh, Pramod Pujari et al. · The Lancet Oncology · 2023 · 35 citations

Vaccination, Vaccine Safety, Vaccinology +12

Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years – updated evidence from Indian follow-up cohort study

Partha Basu, Richard Muwonge, Neerja Bhatla et al. · Papillomavirus Research · 2019 · 32 citations · Full text

Human papillomavirus infection among human immunodeficiency virus-infected women in Maharashtra, India

Smita Joshi, Janki Mohan Babu, D.b Jayalakshmi et al. · Vaccine · 2014 · 28 citations · Full text

Sexual Health, Cervical Cancer, Human Papillomavirus Vaccines +6